This increases every four weeks until they reach the first maintenance dose of 2.4 mg
Retatrutide is an unapproved investigational triple agonist (GLP-1, GIP, glucagon receptors) not licensed by the MHRA, EMA, or FDA for routine clinical use
This blend is used in preclinical research investigating synergistic effects on connective tissue repair, wound healing, and muscle recovery
While it may be tempting to stack these supplements to stimulate both alertness and focus, Huberman recommends experimenting with them separately to help pinpoint the exact ingredient that best supports your health goals
After propensity-score matching, the two cohorts (1051 in each cohort, mean age 52.6 years, 41.5% women, 16.6% black, 66.2% white, 7.4% Hispanic) were balanced (Table 2)
IV Elements offers same-day appointments at our drip lounges in Hoboken, Asbury Park, Parsippany, and Marlton